News
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has announced the retirement of Dr. Richard Geary, the current Chief Development ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Richard Geary, Ph.D., executive vice president and chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback